CARVIDON MR S (Trimetazidine (35mg))

Carvidon-MR Tablet is indicated for the management of angina pectoris, a condition characterized by chest discomfort resulting from insufficient blood flow to the heart. This medication enhances the heart’s efficiency in utilizing oxygen and provides protection to heart cells under conditions of reduced oxygen availability, thereby diminishing both the frequency and intensity of angina episodes. It is essential to adhere to the dosage prescribed by your healthcare provider, which is typically two times a day alongside meals. To maximize the benefits of the treatment, individuals are encouraged to integrate heart-friendly lifestyle practices, such as engaging in regular exercise, ceasing tobacco use, and maintaining a nutritious, low-fat diet. Skipping doses or discontinuing the medication without consulting a healthcare professional is not advisable, as it may lead to a resurgence of symptoms. While the medication is generally well tolerated, if any adverse effects persist beyond a short duration or worsen, it is important to consult with your physician. Additionally, Carvidon-MR Tablet is not designed to address sudden episodes of chest pain (acute angina) and should not be administered to individuals with Parkinson’s disease, movement disorders, or significant renal impairment. Caution is advised when driving or operating machinery if you experience dizziness or instability while on this medication. It is also crucial to keep your physician informed about any other medications you are taking or health issues you may have.